Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.10.30
关于调解中国银行授信额度暨公司提供担保的通告
2020.10.30
第五届监事会第三次聚会决议通告
2020.10.30
第五届董事会第四次聚会决议通告
2020.10.30
关于召开2020年第四次暂时股东大会的通知通告
2020.10.28
关于“19海普01”投资者回售效果通告
2020.10.27
关于依诺肝素钠注射液率先通过仿制药一致性评价的通告
2020.10.27
2019年面向及格投资者果真刊行公司债券(第一期)2020年度付息通告
2020.10.27
关于依诺肝素钠注射液率先通过仿制药一致性评价的通告
2020.10.26
2019年面向及格投资者果真刊行公司债券(第一期)2020年度付息通告
2020.10.24
关于对全资子公司增资并加入投资设立医疗基金的通告
第一页
上一页
23
24
25
26
27
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】